[1]
|
W. M. Pardridge, “Molecular Trojan Horses for Blood-Brain Barrier Drug Delivery,” Current Opinion in Pharmacology, Vol. 6, No. 5, 2006, pp. 494-500.
doi:10.1016/j.coph.2006.06.001
|
[2]
|
Y. Seow and M. J. Wood, “Biological Gene Delivery Vehicles: Beyond Viral Vectors,” The American Society of Gene Therapy, Vol. 17, No. 5, 2009, pp. 767-777.
|
[3]
|
K. M. Kroeger, A. K. M. G. Muhammad, G. J. Baker, H. Assi, M. K. Wibowo, W. Xiong, K. Yagiz, M. Candolfi, P. R. Lowenstein and M. G. Castro, “Gene Therapy and Virotherapy: Novel Therapeutic Approaches for Brain Tumors,” Discovery Medicine, Vol. 10, No. 53, 2010, pp. 293-304.
|
[4]
|
A. Villaverde, “Nanotechnology, Bionanotechnology and Microbial Cell Factories,” Microbial Cell Factories, Vol. 9, 2010, pp. 53-56. doi:10.1186/1475-2859-9-53
|
[5]
|
I. Tatischeff, F. Lavialle, C. de Paillerets, H. Weintraub, G. Tham and A. Alfsen, “Carcinogenic Benzo(a)pyrene and Non-Carcinogenic Benzo(e)pyrene Discriminated by Dictyostelium discoideum Cells Through Internalization,” In: P. Garrigues and M. Lamotte, Eds., Polycyclic Aromatic Compounds, PAH XIII, Gordon and Breach Science Publishers, Switzerland, 1993, pp. 695-702.
|
[6]
|
I. Tatischeff and F. Lavialle, “Immunological Evidence of a P-Glycoprotein in the Microorganism Dictyostelium,” Comptes Rendus de l'Académie des Sciences III (Paris), Vol. 316, No. 6, 1993, pp. 560-563.
|
[7]
|
I. Tatischeff, M. Bomsel, C. de Paillerets, H. Durand, B. Geny, D. Segretain, E. Turpin and A. Alfsen, “Dictyostelium discoideum Cells Shed Vesicles with Associated DNA and Vital Stain Hoechst 33342,” Cellular and Molecular Life Sciences, Vol. 54, No. 5, 1998, pp. 476-487.
doi:10.1007/s000180050176
|
[8]
|
I. Tatischeff, F. Lavialle, S. Pigaglio-Deshayes, C. Péchoux-Longin, L. Chinsky and A. Alfsen, “Dictyostelium Extracellular Vesicles Containing Hoechst 33342 Transfer the Dye into the Nuclei of Living Cells: a Fluorescence Study,” Journal of Fluorescence, Vol. 18, No. 2, 2008, pp. 319-328. doi:10.1007/s10895-007-0271-4
|
[9]
|
F. Lavialle, S. Deshayes, F. Gonnet, E. Larquet, S. G. Kruglik, N. Boisset, R. Daniel, A. Alfsen and I. Tatischeff, “Nanovesicles Released by Dictyostelium Cells: a Potential Carrier for Drug Delivery,” International Journal of Pharmaceutics, Vol. 380, No. 1-2, 2009, pp. 206-215. doi:10.1016/j.ijpharm.2009.06.039
|
[10]
|
D. J. Watts and M. Ashworth, “Growth of Myxameobae of the Cellular Slime Mould Dictyostelium discoideum in Axenic Culture,” Biochemical Journal, Vol. 119, No. 2, 1970, pp. 71-174.
|
[11]
|
J. Gruenberg, “Lipids in Endocytic Membrane Transport and Sorting,” Current Opinion in Cell Biology, Vol. 15, No. 4, 2003, pp. 382-388.
doi:10.1016/S0955-0674(03)00078-4
|
[12]
|
T. Kobayashi, K. Startchev, A. J. Whitney and J. Gruenberg, “Localization of Lysobisphosphatidic Acid-Rich Membrane Domains in Late Endosomes,” Biological Chemistry, Vol. 382, No. 3, 2001, pp. 483-485.
doi:10.1515/BC.2001.059
|
[13]
|
T. Kobayashi, M. H. Beuchat, J. Chevallier, A. Makino, N. Mayran, J. M. Escola, C. Lebrand, P. Cosson, T. Kobayashi and J. Gruenberg, “Separation and Characterization of Late Endosomal Membrane Domains,” Journal of Biological Chemistry, Vol. 277, No. 35, 2002, pp. 32157- 32164. doi:10.1074/jbc.M202838200
|
[14]
|
C. Yorikawa, H. Shibata, S. Waguri, K. Hatta, M. Horii, K. Katoh, T. Kobayashi, Y. Uchiyama and M. Maki, “Human CHMP6, a Myristoylated ESCRT-III Protein, Interacts Directly with an ESCRT-II Component EAP20 and Regulates Endosomal Cargo Sorting,” Biochemical Journal, Vol. 387, No. 1, 2005, pp. 17-26.
doi:10.1042/BJ20041227
|
[15]
|
B. Hugel, M. C. Martínez, C. Kunzelmann and J. M. Freyssinet, “Membrane Microparticles: Two Sides of the Coin,” Physiology, Vol. 20, 2005, pp. 22-27.
doi:10.1152/physiol.00029.2004
|
[16]
|
H. F. G. Heijnen, A. E. Schiel, R. Fijnheer, H. J. Geuze and J. J. Sixma, “Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived from Exocytosis of Multivesicular Bodies and Alpha-Granules,” Blood, Vol. 94, No. 11, 1999, pp. 3791-3799.
|
[17]
|
K. Denzer, M. van Eijk, M. J. Kleijmeer, E. Akobson, C. de Groot and H. J. Geuze, “Follicular Dendritic Cells Carry MHC Class II-Expressing Microvesicles at their Surface,” The Journal of Immunology, Vol. 165, No. 3, 2000, pp. 1259-1265.
|
[18]
|
G. Van Niel, G. Raposo, C. Candalh, M. Boussac, R. Hershberg, N. Cerf-Bensussan and M. Heyman, “Intestinal Epithelial Cells Secrete Exosome-Like Vesicles,” Gastroenterology, Vol. 121, No. 2, 2001, pp. 337-349.
doi:10.1053/gast.2001.26263
|
[19]
|
B. Fevrier and G. Raposo, “Exosomes: Endosomal-Derived Vesicles Shipping Extracellular Messages,” Current Opinion in Cell Biology, Vol. 16, No. 4, 2004, pp. 415- 421. doi:10.1016/j.ceb.2004.06.003
|
[20]
|
L. Chernomordik, M. M. Kozlov and J. Zimmerberg, “Lipids in Biological Membrane Fusion,” The Journal of Membrane Biology, Vol. 146, No.1, 1995, pp. 1-14.
doi:10.1007/BF00232676
|
[21]
|
M. P. Wymann and R. Schneiter, “Lipid Signalling in Disease,” Nature Reviews Molecular Cell Biology, Vol. 9, No. 2, 2008, pp. 162-176. doi:10.1038/nrm2335
|
[22]
|
K. Denzer, M. J. Kleijmeer, H. F. G. Heijnen, W. Stoorvogel and H. J. Geuze, “Exosome: From Internal Vesicle of the Multivesicular Body to Intercellular Signaling Device,” Journal of Cell Science, Vol. 113, No. 19, 2000, pp. 3365-3374.
|
[23]
|
A. Delcayre and J. B. Le Pecq, “Exosomes as Novel Therapeutic Nanodevices,” Current Opinion in Molecular Therapy, Vol. 8, No. 1, 2006, pp. 31-38.
|
[24]
|
S. Lakhal and M. J. Wood, “Exosome Nanotechnology: an Emerging Paradigm Shift in Drug Delivery: Exploitation of Exosome Nanovesicles for Systemic in Vivo Delivery of RNAi Heralds New Horizons for Drug Delivery across Biological Barriers,” Bioessays, Vol. 33, No. 10, 2011, pp. 737-741. doi:10.1002/bies.201100076
|
[25]
|
J. A. MacDiarmid, N. B. Mugridge, J. C. Weiss, L. Phillips, A. L. Burn, R. P. Paulin, J. E. Haasdyk, K. A. Dickson, V. N. Brahmbhatt, S. T. Pattison, A. C. James, G. Al Bakri, R. C. Straw, B. Stillman, R. M. Graham and H. Brahmbhatt, “Bacterially Derived 400 Nm Particles for Encapsulation and Cancer Cell Targeting of Chemotherapeutics,” Cancer Cell, Vol. 11, No. 5, 2007, pp. 431-445. doi:10.1016/j.ccr.2007.03.012
|
[26]
|
R. Valenti, V. Huber, M. Iero, P. Filipazzi, G. Parmiani and L. Rivoltini, “Tumor-Released Microvesicles as Vehicles of Immunosuppression,” Cancer Research, Vol. 67, No. 7, 2007, pp. 2912-2915.
doi:10.1158/0008-5472.CAN-07-0520
|
[27]
|
C. Bies, C. M. Lehr and J. F. Woodley, “Lectin-Mediated Drug Targeting: History and Applications,” Advanced Drug Delivery Reviews, Vol. 56, No. 4, 2004, pp. 425- 435. doi:10.1016/j.addr.2003.10.030
|
[28]
|
C. Wilhelm, F. Lavialle, C. Péchoux, I. Tatischeff and F. Gazeau, “Intracellular Trafficking of Magnetic Nanoparticles to Design Multifunctional Biovesicles,” Small, Vol. 4, No. 5, 2008, pp. 577-582. doi:10.1002/smll.200700523
|
[29]
|
Y. Lu, J. C. Knol, M. H. K. Linskens, K. Friehs, P. J. M. Van Haastert and E. Flaschel, “Production of the Soluble Human Fas Ligand by Dictyostelium discoideum Cultivated on a Synthetic Medium,” Journal of Biotechnology, Vol. 108, No. 3, 2004, pp. 243-251.
doi:10.1016/j.jbiotec.2003.12.006
|